S&P 500 Futures
(0.26%) 5 535.75 points
Dow Jones Futures
(0.25%) 39 568 points
Nasdaq Futures
(0.26%) 19 979 points
Oil
(0.64%) $82.06
Gas
(-1.81%) $2.55
Gold
(0.35%) $2 347.70
Silver
(0.14%) $29.60
Platinum
(-0.70%) $994.90
USD/EUR
(-0.25%) $0.931
USD/NOK
(-0.30%) $10.64
USD/GBP
(-0.17%) $0.789
USD/RUB
(2.09%) $87.52

实时更新: Aquestive Therapeutics [AQST]

交易所: NASDAQ 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间29 Jun 2024 @ 04:00

0.39% $ 2.60

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
Our systems believe the stock currently is overvalued by -0.47% compare to its pairs and should correct downwards.
Profile picture for Aquestive Therapeutics Inc

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally...

Stats
今日成交量 10.20M
平均成交量 1.85M
市值 236.70M
EPS $-0.170 ( Q1 | 2024-05-07 )
下一个收益日期 ( $-0.110 ) 2024-08-05
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.78
(Sector) 42.63
(Industry) 0
ATR14 $0.00700 (0.27%)
ACOR -24.02%
ACRX 7.50%
ADMP 0.85%
ADMS 0.00%
AGRX -1.40%
AKAN -3.75%
ALIM 0.54%
AMPH -0.87%
AMYT 0.00%
ANIP 0.94%
AQST 0.39%
ASRT -5.34%
ATNX 0.00%
AVDL -1.75%
AYTU 0.00%
BFRI -2.39%
BGXX -34.22%
CLVR -2.22%
COLL -0.74%
CPIX 0.66%
CRDL 1.00%
CRON -0.43%
CYTH 5.83%
DCPH 0.00%
DERM 9.73%
DRRX -5.49%
DVAX -1.23%
EGRX 11.55%
EMBC 0.32%
EMBCV -9.33%
EOLS -0.73%
ESPR -3.90%
EVOK 5.48%
FLGC 6.71%
FLXN 0.00%
GHSI -0.35%
HCM -1.83%
HROW -0.52%
HUGE -4.71%
IMCC 2.20%
INCR 2.03%
IRWD 5.16%
ITCI -3.51%
IXHL 10.53%
JUPW 11.76%
KALA 9.92%
KIN 0.11%
KMDA -1.78%
LNTH -1.25%
NBIX 2.50%
NEPT 0.00%
NLTX 1.45%
OGI -3.75%
OPTN -3.70%
ORGO 6.06%
PAHC -2.50%
PCRX 2.51%
PETQ -0.45%
PLXP 0.00%
PPD 0.00%
PROC -0.40%
PRPH -2.11%
PTPI 2.69%
RDHL -2.58%
RDUS 4.30%
REPH -0.48%
RGC -5.88%
RMTI 0.00%
SCTL 0.92%
SCYX -1.48%
SIGA 3.13%
SISI -13.33%
SNDL -1.04%
SNOA 1.05%
SSIC 1.03%
SUPN -0.45%
SXTC -2.24%
THTX 0.00%
TKNO -1.44%
TLGT -13.85%
TLRY -4.05%
TXMD -7.47%
TYHT -3.90%
UPC -1.97%
VTRS 1.43%
ZYNE 2.36%
Insider Trading
Date Person Action Amount type
2024-06-20 Morris Timothy E Buy 38 000 Stock Option (right to purchase)
2024-06-20 Taglietti Marco Buy 38 000 Stock Option (Right to Purchase)
2024-06-20 Brown Gregory B Buy 38 000 Stock Option (Right to Purchase)
2024-06-20 Krop Julie Buy 38 000 Stock Option (Right to Purchase)
2024-06-20 Cochran John Buy 38 000 Stock Option (Right to Purchase)
INSIDER POWER
87.07
Last 98 transactions
Buy: 5 885 486 | Sell: 282 172
相关性 (AI algo v.1.1b): Overvalued: -0.47% $2.59 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量 相关性

長: 0.32 (neutral)
短: -0.59 (weak negative)
Signal:(32.852) Neutral

Aquestive Therapeutics 相关性

10 最正相关
OZEM1
CCLDO0.967
REBN0.95
NATL0.945
HUMA0.938
VTYX0.923
LIDR0.914
CCLD0.914
HUMAW0.913
EUDA0.911
10 最负相关
FTRE-0.95
NAAS-0.928
AERT-0.89
PZZA-0.889
LRHC-0.873
GIGM-0.873
IVP-0.871
BLMN-0.866
HOVR-0.865
AAPD-0.862

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Aquestive Therapeutics 相关性 - 货币/商品

The country flag 0.06
( neutral )
The country flag 0.19
( neutral )
The country flag 0.00
( neutral )
The country flag -0.19
( neutral )
The country flag 0.00
( neutral )
The country flag -0.16
( neutral )

Aquestive Therapeutics 财务报表

Annual 2023
营收: $50.58M
毛利润: $29.97M (59.25 %)
EPS: $-0.130
FY 2023
营收: $50.58M
毛利润: $29.97M (59.25 %)
EPS: $-0.130
FY 2022
营收: $47.68M
毛利润: $28.29M (59.34 %)
EPS: $-1.240
FY 2021
营收: $50.83M
毛利润: $50.83M (100.00 %)
EPS: $-2.10

Financial Reports:

No articles found.

Aquestive Therapeutics Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Aquestive Therapeutics

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。

Total Execution Time: 1.0087838172913 seconds
Number of API calls: 3
Number of DB calls: 9